dc.contributor.author |
Tatarin, A. E. |
|
dc.date.accessioned |
2020-06-24T10:31:05Z |
|
dc.date.available |
2020-06-24T10:31:05Z |
|
dc.date.issued |
2019 |
|
dc.identifier.citation |
TATARIN, A. E. Experience of VenaSeal system using in treatment of chronic venous insufficiency. In: Arta Medica. 2019, nr. 3(72), pp. 91-92. ISSN 1810-1852. |
en_US |
dc.identifier.issn |
1810-1852 |
|
dc.identifier.uri |
https://artamedica.md/old_issues/ArtaMedica_72.pdf |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/10690 |
|
dc.description |
Highly Specialized Clinical Center for Cardiovascular and X-ray Vascular Surgery with an Intensive Care Unit, Vinnytsya
Regional Clinical Hospital Named After M.I. Pirogov, Department of Endoscopic and Cardiovascular Surgery, National
Pirogov Memorial Medical University, Vinnytsya, Ukraine, Al XIII-lea Congres al Asociației Chirurgilor „Nicolae Anestiadi” și al III-lea Congres al Societății de Endoscopie, Chirurgie miniminvazivă și Ultrasonografie ”V.M.Guțu” din Republica Moldova |
en_US |
dc.description.abstract |
Introduction: The VenaSeal device is a disposable, single use system for administering cyanoacrylate adhesive into an incompetent
truncal vein which can be used without tumescent anesthesia and without application of heat.
The aim of the study was to evaluate our experience of VenaSeal system using.
Methods: Our experience included 9 patients (16 lower limbs) with chronic venous insufficiency C2-C4 (CEAP). 2 patients received monoprocedures of VenaSeal, 2 patients – VenaSeal + miniflebectomy, 4 patients – VenaSeal + foam sclerotherapy, 1 patient – RFA
of great saphenous vein + VenaSeal closure of perforator vein.
Results: The average diameter of the treated vein area in patients of our study was 9.5±2.0 mm. Cyanoacrylate embolization was
associated with low pain scores. Moreover, presumably because it does not require tumescent anesthesia, treatment resulted by the
absence of ecchymosis. Our patients had no postoperative burns and pigmentation at all. Also, there was no even mild paresthesia
in any patient.
According to ultrasonography great saphenous veins were closed in all patients both on day 3 and on day 30. The severity and impact
of venous disease on quality of life were measured with several end points in our study. Subjects treated with VenaSeal system
showed significantly improving of quality of life over time.
Conclusions: Using of VenaSeal is a fast and effective method of eliminating the incompetence of the saphenous veins, without
the need for tumescent anesthesia, wearing compression knitwear, not accompanied by paresthesias, postoperative burns and
pigmentation. |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova |
en_US |
dc.subject |
chronic venous insufficiency |
en_US |
dc.subject |
cyanoacrylate embolization |
en_US |
dc.subject |
VenaSeal |
en_US |
dc.subject.mesh |
Venous Insufficiency--diagnosis |
en_US |
dc.subject.mesh |
Chronic Disease |
en_US |
dc.subject.mesh |
Venous Insufficiency--complications |
en_US |
dc.subject.mesh |
Venous Insufficiency--therapy |
en_US |
dc.subject.mesh |
Critical Pathways--trends |
en_US |
dc.subject.mesh |
Lower Extremity--blood supply |
en_US |
dc.subject.mesh |
Combined Modality Therapy |
en_US |
dc.subject.mesh |
Embolization, Therapeutic--methods |
en_US |
dc.subject.mesh |
Cyanoacrylates--therapeutic use |
en_US |
dc.title |
Experience of VenaSeal system using in treatment of chronic venous insufficiency |
en_US |
dc.type |
Other |
en_US |